EnterNext welcomes Quantum Genomics on Alternext's market in Paris

Lionel Segard, CEO of Quantum Genomics, closes the European trading day in Paris.

Quantum Genomics specializes in the research and development of drugs used to treat cardiovascular, neurological, and metabolic disorders.